IP Library Granted Patent US 10,584,176
Granted Patent B2
US 10,584,176 · App. 16/138,605 · Granted Mar 10, 2020

Fc variants with increased affinity for FcγRIIc

Inventors: Gregory Lazar (Pacifica, CA); Wei Dang (Pasadena, CA); John Desjarlais (Pasadena, CA); Sher Bahadur Karki (Santa Monica, CA); Omid Vafa (Monrovia, CA); Robert Hayes (Thousand Oaks, CA)
Assignee: Xencor, Inc.
C07K16/2893C07K16/00C07K16/18C07K16/2863C07K16/2887C07K16/2896C07K16/30C07K16/32A61K2039/505C07K2317/24C07K2317/31C07K2317/34C07K2317/40C07K2317/41C07K2317/52C07K2317/56C07K2317/64C07K2317/71C07K2317/72C07K2317/732C07K2317/734C07K2317/77C07K2317/92C07K2317/94
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,584,176
App. No.
16/138,605
Granted
Mar 10, 2020
Kind
B2
Abstract

The present invention relates to Fc variants having increased affinity for FcγRIIc, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.

Claims (10)

1. A nucleic acid encoding a protein comprising an Fc variant of a parent Fc polypeptide, wherein the Fc variant comprises amino acid substitutions 239D, 332E and 330L, and numbering is according to the EU index.

2. The nucleic acid of claim 1 , wherein the parent Fc polypeptide is human IgG1.

3. The nucleic acid of claim 1 , wherein the protein is an antibody.

4. The nucleic acid of claim 3 , wherein the antibody is selected from the group consisting of a human antibody, a humanized antibody, and a chimeric antibody.

5. The nucleic acid of claim 1 , wherein the protein is an Fc fusion protein.

6. An expression vector comprising the nucleic acid of claim 1 .

7. A host cell comprising the nucleic acid of claim 1 .

8. A host cell comprising the expression vector of claim 6 .

9. A method of making a protein comprising: a) culturing the host cell of claim 7 under conditions wherein the protein is expressed; and b) recovering the protein.

10. A method of making a protein comprising: a) culturing the host cell of claim 8 under conditions wherein the protein is expressed; and b) recovering the protein.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: LAZAR, GREGORY ALAN; DANG, WEI; DESJARLAIS, JOHN R.; KARKI, SHER BAHADUR; VAFA, OMID; HAYES, ROBERT
To: XENCOR, INC.
Reel/Frame 051636/0165 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: VIELMETTER, JOST
To: XENCOR, INC.
Reel/Frame 051636/0194 →
Continuity (7)
Continuation 14578305 · Dec 19, 2014
Division 11841654 · Aug 20, 2007
Continuation 11124620 · May 5, 2005
Continuation In Part 10822231 · Mar 26, 2004
Continuation In Part 10672280 · Sep 26, 2003
Continuation In Part 10379392 · Mar 3, 2003
Related Publication 20190071512A1 · Mar 7, 2019
Cited By (1)
US 12,338,278